We have previously reported a neuroprotective role of C1q in the absence of triggering downstream activation [12, 13], but we and others have also demonstrate a beneficial effect of a genetic ablation of C1q, C3 and CR3 in AD mouse models [14–16]. Here, C3 is linked to Alzheimer disease.